{
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Dementia with Lewy Bodies\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"G30.3\",\n        \"reasoning\": \"Progressive fatigue, weight loss, and intermittent confusion, along with hallucinations (as suggested by 'seeing things that aren't there') and personality changes, are characteristic of Dementia with Lewy Bodies\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Alzheimer's Disease\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"G31.0\",\n            \"reasoning\": \"Similar symptoms, but Alzheimer's is typically more progressive and has more pronounced memory impairments\"\n        },\n        {\n            \"name\": \"Vitamin B12 Deficiency\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"K43.9\",\n            \"reasoning\": \"Anemia and weight loss could be indicative of a B12 deficiency, but this diagnosis is less likely given the presence of visual hallucinations\"\n        },\n        {\n            \"name\": \"Chronic Displacement Syndrome\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"G32.9\",\n            \"reasoning\": \"Confusion and disorientation could be indicative of chronic displacement syndrome, but this diagnosis is less likely given the presence of hallucinations\"\n        }\n    ],\n    \"key_findings\": [\n        \"Mild anemia\",\n        \"Slightly elevated calcium\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Complete Blood Count (CBC)\",\n            \"purpose\": \"Rule in anemia\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Electrolyte Panel\",\n            \"purpose\": \"Rule in elevated calcium\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Cognitive Assessment\",\n            \"purpose\": \"Evaluate cognitive function\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Start patient on cholinesterase inhibitors (e.g., donepezil, rivastigmine)\",\n            \"Order comprehensive geriatric assessment\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Donepezil\",\n                \"dose\": \"10mg PO daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Continue until symptoms improve or stabilize\",\n                \"rationale\": \"Cholinesterase inhibitors are first-line treatment for Dementia with Lewy Bodies\"\n            }\n        ],\n        \"monitoring\": [\n            \"Patient's cognitive function\",\n            \"Frequency: weekly\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Geriatric Psychiatrist\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To evaluate and manage hallucinations\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Increased risk of falls\",\n        \"Vision and hearing loss\"\n    ],\n    \"patient_education\": [\n        \"Patient should be educated on the importance of adherence to treatment plan and self-management strategies\",\n        \"Family members should be educated on how to safely manage patient's care\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Every 3 months\",\n        \"conditions\": [\n            \"Assessment of cognitive function\",\n            \"Evaluation of treatment efficacy\"\n        ]\n    },\n    \"confidence_in_assessment\": 0.9,\n    \"uncertainties\": [\n        \"Patient's response to treatment\",\n        \"Presence or absence of other comorbidities\"\n    ]\n}",
  "error": null,
  "timestamp": "2025-08-09T21:50:27.748970",
  "tokens_used": 2143,
  "latency": 6.105423212051392,
  "model_id": "meta-llama/llama-3.2-3b-instruct:free",
  "cache_version": "v2.0_standardized_json",
  "cached_at": "2025-08-09T21:50:27.749064"
}